On 29 April 2022, Knowledge Ecology International Europe (KEI Europe) made the following submission on the European Union’s revised framework for compulsory licensing of patents. 1. In the European Union (EU)’s revised framework for compulsory licensing of patents, the EU anticipates establishing an EU-level compulsory licence for use in a crisis, acknowledging that a patchwork …
On 31 March 2022, the Office of the United States Trade Representative (USTR) published its 2022 National Trade Estimate Report on Foreign Trade Barriers (NTE). As USTR notes in “accordance with section 181 of the Trade Act of 1974, as amended by section 303 of the Trade and Tariff Act of 1984 and amended by section …
2022: USTR takes aim at Europe over pharmaceutical pricing and reimbursement policies Read More »
KEI Europe comments on the European Health Emergency Preparedness and Response Authority (HERA) road map 24 February 2021 Whilst calls for better coordination in the EU pandemic response are welcome, HERA must put the global right to health, rather than regional biosecurity concerns, at its heart. Rapid operationalisation, as demanded by global public health needs, …
Update: On Wednesday, 25 November 2020, the European Commission published its IP action plan: Making the most of the EU’s innovative potential – An intellectual property action plan to support the EU’s recovery and resilience. KEI Europe’s President, Dr. Ellen ‘t Hoen provided the following reaction to the European Union’s action plan on intellectual property. …
14 August 2020 Compulsory licensing in the Unitary Patent System. There should be a provision for a unitary compulsory license in the unitary patent system, that is without prejudice to national compulsory licenses on the unitary patent right. Non patent market exclusivities. Sui generis exclusive rights regimes, such as but not limited to regulatory test …
On 31 March 2020, the Office of the United States Trade Representative (USTR) published its 2020 National Trade Estimates Report on Foreign Trade Barriers (NTE). As USTR notes, in “accordance with section 181 of the Trade Act of 1974, as amended by section 303 of the Trade and Tariff Act of 1984 and amended by …
2020: USTR takes aim at Europe over pharmaceutical pricing and reimbursement policies Read More »
On 8 January 2020 the European Commission published a “Report on the protection and enforcement of intellectual property rights in third countries.” The objective of this report is to “identify third countries in which the state of IPR protection and enforcement (both online and offline) gives rise to the greatest level of concern” (European Commission, …
On Thursday, 7 November 2019, 21 civil society organizations and 24 individuals including public health experts, and legal analysts sent a letter to Italy’s new Minister of Health, Roberto Speranza expressing support for Dr Luca Li Bassi, the current Director General of Agenzia Italiana del Farmaco (AIFA). The pdf version of the letter can be …
Letter to Italian Minister of Health in support of Dr Luca Li Bassi Read More »
UPDATE: On Wednesday, 15 August 2018, WHO Director-General, Dr Tedros Adhanom Ghebreyesus provided a response to the open letter on the Roadmap on Access to Medicines and Vaccines 2019-2023. The Director-General’s response can be found here: WHO DG letter to KEI 15 August 2018 Access roadmap On Friday, 3 August 2018, 16 groups sent an …
On 27 June 2018, a small group of activists and public health campaigners organized a demonstration in front of Austria’s Health Ministry. Banners displayed the following messages: “Austrian Presidency of the EU: put patients before profits”, “Pharma 3 – Patients 0”, and “Pharma score goals with high prices”. KEI Europe, along with 11 other groups …
Civil Society Asks Upcoming Austrian EU Presidency To Defend Access To Medicines Read More »
